Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. ZENMOLIN SYRUP 2 MG/5 ML [SIN00022P]

ZENMOLIN SYRUP 2 MG/5 ML [SIN00022P]

Active ingredients: ZENMOLIN SYRUP 2 MG/5 ML

Last updated 26 October 2025

Product Info

ZENMOLIN SYRUP 2 MG/5 ML

[SIN00022P]

Product information

Active Ingredient and Strength

SALBUTAMOL SULPHATE EQV SALBUTAMOL - 2 MG/5 ML

Dosage Form

SYRUP

Manufacturer and Country

PT ACTAVIS INDONESIA - INDONESIA REP OF

Registration Number

SIN00022P

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Forensic Classification

PHARMACY ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

R03CC02

INDICATIONS:
For the relief and prevention of bronchospasm in bronchial asthma, in chronic bronchitis, and in emphysema.

Bronchodilators should not be the only or main treatment in patients with persistent asthma. In patients with persistent asthma unresponsive to ZENMOLIN, treatment with inhaled corticosteroids is recommended to achieve and maintain control. Failing to respond to treatment with ZENMOLIN may signal a need for urgent medical advice or treatment.

RECOMMENDED DOSAGE: Orally

Table caption

Adults :

10 – 20 ml (5ml for elderly and sensitive patients)

Children :

2 – 5 yrs : 2.5 – 5ml

6 – 12 yrs : 5ml

Over 12 years: 5–10 ml

Doses to be given 3 – 4 times daily.

Special patient groups:
In elderly patients or in those known to be unusually sensitive to beta-adrenergic stimulant drugs, it is advisable to initiate treatment with 2 mg (5ml) salbutamol 3 or 4 times per day.

Contraindications
Salbutamol syrup is contraindicated in patients with a history of hypersensitivity to any of its components.
Non-i.v. formulations of Salbutamol must not be used to arrest uncomplicated premature labour or threatened abortion.